Vaccines

New vaccines that use antibodies to prevent opioids from causing a “high” could help stem abuse and fatal overdoses if human trials are successful.

Tracking, reporting, and organizing immunization-related data is difficult but can improve patient care. HIMSS has recognized several products through its voluntary testing program that can do that job and work with electronic health record systems.

A therapy that uses the immune system to fight cancer has been 97% effective in mice and is moving to human trials.

A new program developed with the support of CDC aims to streamline vaccine-related functions in EHRs to make administration and reporting easier for clinicians.

There is a new vaccine against shingles, and ACIP has recommended that it replace its predecessor.

Patients are increasingly turning to the Internet to have questions about vaccines answered, highlighting the need for increased education at the time of vaccination.

A new study reveals that certain genes may play a role in how effectively the body produces antibodies against the flu after vaccination.

Imagine if you could administer an entire vaccine series in just one shot. That technology might be on the horizon, thanks to researchers at MIT.

Adults who don’t know they need or refuse measles vaccinations before international travel introduce more than half of new U.S. measles cases.

Regardless of whether the chicken or the egg came first, the caterpillar may have the edge when it comes to vaccine production, a new report finds.

Those age 65 and older faced the most cases of the flu and were most often hospitalized during the 2016-17 season, according to new CDC data.

Vaccine-related injuries in adults are rising, but healthcare providers administering those vaccines rarely have to worry about liability claims.

Researchers have developed a microneedle patch that could replace injections for influenza vaccination and a host of other diseases.

U.K. researchers say more research and funding is needed for a more successful alternative to prevent pneumonia infection.

A new report says the key to increasing adult vaccine compliance may lie in a simple suggestion from a physician.

The federal agency supports a vaccine fast-tracked by the FDA for adults traveling to one of the more than 50 countries where cholera is endemic.

Pharmacies can help reach populations that have difficulty in using traditional channels for vaccines, but obstacles remain.

A vaccine targeting the protein that contributes to acne breakouts is in development at the University of California, San Diego.

Patients often go without vaccines due to cost, and physicians don’t always recommend them over concerns about reimbursement, according to a new study.

Researchers believe a vaccine could be developed to prevent the formation of celiac disease and possibly other autoimmune disorders.

A simple prompt reminding patients of their flu shot was found to be highly effective in a trial run at the University of Pennsylvania.

The newly discovered antibodies can fight nearly every strain of HIV in existence, according to study authors.

Between public skepticism on vaccinations and provisions of the American Health Care Act, some representing physicians are voicing concern.

Researchers find callers to a national health center were most concerned about the safety and components of vaccines based largely on old information.

Study provides new insight on isolating and suppressing immune cells that could play a vital role in inhibiting other immunotherapy efforts against cancer.

The prevalence of mumps in the state is reinvigorating the question about whether a third dose of measles, mumps and rubella vaccination is warranted.

Saliva-based testing may be just as effective as serum in assessing antibodies against infections like community-acquired pneumonia, according to a new UK study.

Researchers and physicians are working together to discover why adults skip recommended vaccines and what doctors can do to increase immunization rates.

Lead researcher hopes results of new study motivates more adults to improve vaccination compliance.

A new vaccine against Alzheimer’s targets two proteins involved in the development of the disease in hopes to offer both early and late protection.